Publication | Closed Access
In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies
65
Citations
15
References
2019
Year
Olorofim shows encouraging in vitro activity against cryptic species of Aspergillus that can be hard to treat with current antifungal therapies. Further studies are warranted in order to assess its efficacy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1